-150x150.jpg)
Beta blockers are go-to meds for many people who’ve survived a heart attack. However, new Swedish research has found that they might not be needed for heart attack survivors whose hearts have retained a normal pumping ability. Using them in this group might even raise patients’ odds for depression, the data showed. “We found that beta blockers led to slightly higher levels of depression symptoms in patients who had had a heart attack but were not suffering from heart failure,” said study lead author Philip Leissner, a doctoral student in cardiac psychology at Uppsala University. “At the same time, beta blockers have no life-sustaining function for this group of patients,” he said in a university news release. His team published its findings recently in the European Heart Journal. Heart doctors have for decades relied on beta blocker medications to help heart patients — the drugs work by lowering the effects of adrenaline on the heart. But recent advances mean there are now more pharmaceutical options for cardiologists to pick from for people who’ve survived a heart attack, putting the use of beta-blockers into question. According to Leissner’s team, that’s especially true for folks who have survived a heart attack but whose cardiac pumping action has retained its efficacy. In a study published in April, the Swedish researchers found beta-blockers to be unnecessary for this… read on > read on >